$UNH

Healthcare surged in June. Raymond James is adding these two dividend payers to list of top picks

Healthcare rose more than 6% in June as investors favored defensives over tech. Raymond James refreshed its healthcare top-picks list, adding UnitedHealth Group (UNH) and Janus Living (JAN). UNH is up 28% YTD; Q1 adjusted EPS $7.23 on $111.72B revenue; raised dividend to $2.32. JAN, an REIT, debuted in March IPO at $20 and closed at $28.99; dividend yield 1.96%.

Original reporting
Published Jul 2, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Healthcare surged in June. Raymond James is adding these two dividend payers to list of top picks — source image
Decision brief

The 30-second read

$UNHBullishLow
01

Why it matters

The actionable element is the analyst-driven catalyst framing: UNH is tied to an upcoming earnings date and margin/cost moderation thesis; JAN is tied to improving occupancy/margins and acquisition sourcing in seniors housing.

02

Market read

This is a buy-list refresh during a defensive rotation; it may influence short-term positioning but lacks new company-specific disclosures beyond previously referenced results and a dividend hike.

03

What to watch

For UNH, the article cites moderating cost trends but provides no new datapoint beyond prior quarter results; for JAN, the piece doesn’t quantify acquisition pipeline or occupancy trajectory, leaving execution risk.

Relevance 4/10Novelty 4/10Timing: into the July 16 UNH earnings window; post-list refresh for JAN

Background

Healthcare outperformed in June (+6% per the article) as investors rotated away from software and mega-cap tech; Raymond James refreshed its top picks with dividend payers.

Company-level read

Ticker impact

$UNHBullishMedium confidence
Context

Raymond James added UnitedHealth to its top healthcare picks, citing near-term upside around the July 16 earnings report and improving margins.

Expected impact

Moderate upside bias into the July 16 earnings window; limited impact beyond sentiment unless earnings confirm margin/cost moderation.

Evidence & confidence

The article is an analyst note update (not a new earnings print), but it includes concrete guidance context (prior quarter beat, raised full-year EPS, dividend hike) and a dated upcoming earnings catalyst.

$JANBullishMedium confidence
Context

Raymond James recommended Janus Living as a top pick, pointing to improving seniors housing fundamentals and acquisition sourcing in a fragmented market.

Expected impact

Potential near-term support from buy-list momentum; upside likely capped unless fundamentals or acquisition pipeline accelerates.

Evidence & confidence

This is primarily a promotional/strategy update, but it contains specific fundamental drivers and notes the IPO timing and current dividend yield, which can matter for positioning.

Market effects

Reinforces a defensive rotation into healthcare and dividend payers after tech weakness; may support relative performance of managed care and seniors housing.

Primarily US equity flows; no explicit cross-region catalyst beyond sector rotation.

Limited—framed as US healthcare positioning and cost-trend/margin dynamics.

Counterpoint

Top-pick additions can lag fundamentals; if medical cost trends re-accelerate or occupancy recovery stalls, the thesis could unwind despite the endorsement.

Key entities

  • UnitedHealth Group

    Added to Raymond James’ top healthcare picks; thesis centers on July 16 earnings upside, moderating medical costs, improving insurance/Optum margins, and a recent dividend increase.

  • Janus Living

    Added as a top pick; thesis centers on improving seniors housing fundamentals (occupancy, limited new supply, demographics) and acquisition sourcing in a fragmented market.

  • Raymond James

    Investment bank refreshing its top healthcare picks list with two dividend-paying stocks.

Related articles

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$UNHMed

COMMENTARY: Trump administration finds a new way to punish Medicare members — Hiking their drug bills

The article says the Trump administration, led by Medicare chief Mehmet Oz, will end the Part D Premium Stabilization Demonstration subsidy for Medicare drug coverage on Dec. 31 instead of continuing through at least 2027. It cites GAO cost estimates of about $9.8B over two years and warns premiums for 23M enrollees could rise, including possible doubling for 11M.

$UNHMed

Minnesota’s Largest Private Employer Just Reduced Medicare Advantage Coverage for Minnesota Seniors — Here Is What to Do Before October 15

UnitedHealth Group’s UnitedHealthcare will reduce Medicare Advantage coverage in Minnesota and other states for 2026, citing weaker CMS payments and higher medical costs. According to Modern Healthcare’s CMS data analysis, UHC cut about 930,000 MA members nationally, from 10.3M to under 9.4M. UHC suspended full-year earnings guidance and flagged $4B profit risk, shifting many PPO plans to HMO.

$JANLow

Janus Living, Inc. (JAN): Results of Operations and Financial Condition

Janus Living, Inc. (JAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.3 4 ex99306302026.htm EX-99.3 Document Exhibit 99.3 Discussion and Reconciliation of Janus Living's Non-GAAP Financial Measures June 30, 2026 (Unaudited) Definitions Adjusted Fixed Charge Coverage Fixed Charge Coverage Adjusted EBITDAre divided by Fixed Charges. Adjusted Fi

$UNHMed

Hiltzik: Yet another GOP attack on Medicare

According to the article, Medicare chief Mehmet Oz announced July 29 that the Part D Premium Stabilization Demonstration subsidy will end Dec. 31 instead of continuing through at least 2027. The change could raise premiums for 23 million Part D enrollees, including possible doubling for 11 million. The GAO estimates the program cost about $9.8 billion over two years.